SIRIRAJ HOSPITAL

🇹🇭Thailand
- Country
- 🇹🇭Thailand
- Ownership
- Private
- Established
- 2012-04-26
- Employees
- 101
- Market Cap
- -
Clinical Trials
122
Active:4
Completed:48
Trial Phases
5 Phases
Phase 1:14
Phase 2:10
Phase 3:5
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (80 trials with phase data)• Click on a phase to view related trials
Not Applicable
44 (55.0%)Phase 1
14 (17.5%)Phase 2
10 (12.5%)Phase 4
7 (8.8%)Phase 3
5 (6.3%)Malnutrition Prevalence and Nutritional Change After Preoperative Nutrition Counseling
Recruiting
- Conditions
- Nutrition Status
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT07125859
- Locations
- 🇹🇭
Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
The Pilot Study of the Utilization of Suggested Immobilization Test (SIT) for Diagnostic Confirmation of Restless Leg Syndrome in Thai Population
Not Applicable
Not yet recruiting
- Conditions
- Restless Leg Syndrome
- First Posted Date
- 2025-08-08
- Last Posted Date
- 2025-08-08
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT07110961
The Role of Angiographic Measurements and Anatomical Correlations in Intra-Aortic Balloon Pump (IABP) Size Selection
Recruiting
- Conditions
- Intra-aortic Balloon Pump
- First Posted Date
- 2025-04-27
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT06947174
- Locations
- 🇹🇭
Siriraj Hospital, Bangkok Noi, Bangkok, Thailand
Budesonide Irrigation in Allergic Rhinitis
Phase 4
Not yet recruiting
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: The budesonide nasal irrigationDrug: The budesonide nasal spray
- First Posted Date
- 2025-01-21
- Last Posted Date
- 2025-01-21
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 78
- Registration Number
- NCT06785662
- Locations
- 🇹🇭
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients with Aspirin Resistance
Phase 3
Recruiting
- Conditions
- Myeloproliferative Neoplasms (MPN)
- Interventions
- Drug: 81-mg aspirin once dailyDrug: 81-mg aspirin twice daily
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Siriraj Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT06740916
- Locations
- 🇹🇭
Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Bangkok Noi, Bangkok, Thailand
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
No news found